Skip to content
Peptilogics receives $3.3 million from CARB-X to develop treatment for fracture-related infections
We use cookies to ensure that we give you the best experience on our website. Please visit carb-x.org/legal/ for more information. By clicking “Ok”, you consent to the use of all cookies.OkI do not consent